Rhenium-188 and Copper-67 Radiopharmaceuticals for the Treatment of Bladder Cancer

Title: Rhenium-188 and Copper-67 Radiopharmaceuticals for the Treatment of Bladder Cancer

Volume: 4 Issue: 1

Author(s): M. Frier

Affiliation:

Keywords: Rhenium-188, Copper-67, Bladder, Cancer, Radioimmunotherapy

Abstract: The favourable nuclear properties of copper-67 and rhenium-188 for therapeutic application are described, together with methods for the chemical synthesis of a number of derivatives. Survival from invasive bladder cancer has changed little over the past 20 years. The intravesicular administration of Cu-67 or Re-188 radiopharmaceuticals in the treatment of bladder cancer offers some promise for improvement in this situation.

Cite this article as:

M. Frier , Rhenium-188 and Copper-67 Radiopharmaceuticals for the Treatment of Bladder Cancer, Mini-Reviews in Medicinal Chemistry 2004; 4 (1) . https://dx.doi.org/10.2174/1389557043487510